{"id":"https://openalex.org/W82844231","doi":"https://doi.org/10.2174/0929867013373165","title":"Agonists at the a4b2 Nicotinic Acetylcholine Receptors Relationships and Molecular Modelling","display_name":"Agonists at the a4b2 Nicotinic Acetylcholine Receptors Relationships and Molecular Modelling","alternate_titles":[],"publication_year":2001,"publication_date":"2001-05-01","ids":{"openalex":"https://openalex.org/W82844231","doi":"https://doi.org/10.2174/0929867013373165","mag":"82844231","pmid":"https://pubmed.ncbi.nlm.nih.gov/11281847"},"language":"en","primary_location":{"id":"doi:10.2174/0929867013373165","doi":"https://doi.org/10.2174/0929867013373165","is_oa":false,"landing_page_url":"https://doi.org/10.2174/0929867013373165","pdf_url":null,"source":{"id":"https://openalex.org/S33159018","display_name":"Current Medicinal Chemistry","issn_l":"0929-8673","issn":["0929-8673","1875-533X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medicinal Chemistry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W82844231"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"J. Tonder","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":false,"raw_author_name":"J. Tonder","raw_affiliation_strings":["Health Care Discovery, Novo Nordisk A/S, Novo Nordisk Park, Malov, DK-2760, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Care Discovery, Novo Nordisk A/S, Novo Nordisk Park, Malov, DK-2760, Denmark","institution_ids":["https://openalex.org/I189090001"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111507453","display_name":"Preben H. Olesen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I189090001","display_name":"Novo Nordisk (Denmark)","ror":"https://ror.org/0435rc536","country_code":"DK","type":"company","lineage":["https://openalex.org/I189090001","https://openalex.org/I2801134892","https://openalex.org/I4210159963"]}],"countries":["DK"],"is_corresponding":true,"raw_author_name":"P. Olesen","raw_affiliation_strings":["Health Care Discovery , Novo Nordisk A-S, DK-276 Malov, Denmark,Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Health Care Discovery , Novo Nordisk A-S, DK-276 Malov, Denmark,Denmark","institution_ids":["https://openalex.org/I189090001"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5111507453"],"corresponding_institution_ids":["https://openalex.org/I189090001"],"apc_list":null,"apc_paid":null,"fwci":2.8852,"has_fulltext":false,"cited_by_count":97,"citation_normalized_percentile":{"value":0.91455396,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"8","issue":"6","first_page":"651","last_page":"674"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11818","display_name":"Nicotinic Acetylcholine Receptors Study","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11818","display_name":"Nicotinic Acetylcholine Receptors Study","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11178","display_name":"Receptor Mechanisms and Signaling","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nicotinic-acetylcholine-receptors","display_name":"nicotinic acetylcholine receptors","score":0.8820000290870667},{"id":"https://openalex.org/keywords/alpha4beta2-nicotinic-receptor","display_name":"alpha4beta2 nicotinic receptor","score":0.824999988079071},{"id":"https://openalex.org/keywords/nicotinic-agonists","display_name":"nicotinic agonists","score":0.9300000071525574},{"id":"https://openalex.org/keywords/nicotinoids","display_name":"nicotinoids","score":0.9129999876022339},{"id":"https://openalex.org/keywords/epibatidine-analogues","display_name":"epibatidine analogues","score":0.8529999852180481},{"id":"https://openalex.org/keywords/anatoxin-a","display_name":"anatoxin-a","score":0.8899999856948853},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.9850000143051147},{"id":"https://openalex.org/keywords/molecular-modeling","display_name":"molecular modeling","score":0.6990000009536743},{"id":"https://openalex.org/keywords/ligand-binding-modes","display_name":"ligand binding modes","score":0.8930000066757202},{"id":"https://openalex.org/keywords/cation-pi-interactions","display_name":"cation-\u03c0 interactions","score":0.7039999961853027},{"id":"https://openalex.org/keywords/hydrogen-bonding","display_name":"hydrogen bonding","score":0.7239999771118164}],"concepts":[{"id":"https://openalex.org/C80161118","wikidata":"https://www.wikidata.org/wiki/Q408520","display_name":"Acetylcholine receptor","level":3,"score":0.7901201248168945},{"id":"https://openalex.org/C188987157","wikidata":"https://www.wikidata.org/wiki/Q7030581","display_name":"Nicotinic agonist","level":3,"score":0.6520572900772095},{"id":"https://openalex.org/C2775910092","wikidata":"https://www.wikidata.org/wiki/Q180623","display_name":"Acetylcholine","level":2,"score":0.5816045999526978},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5484299659729004},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4695756137371063},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.3869776725769043},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3485524654388428},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.28264495730400085},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.24253377318382263}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008958","descriptor_name":"Models, Molecular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009538","descriptor_name":"Nicotine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D009538","descriptor_name":"Nicotine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011978","descriptor_name":"Receptors, Nicotinic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D011978","descriptor_name":"Receptors, Nicotinic","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D011978","descriptor_name":"Receptors, Nicotinic","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D013329","descriptor_name":"Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018722","descriptor_name":"Nicotinic Agonists","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018722","descriptor_name":"Nicotinic Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018722","descriptor_name":"Nicotinic Agonists","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.2174/0929867013373165","doi":"https://doi.org/10.2174/0929867013373165","is_oa":false,"landing_page_url":"https://doi.org/10.2174/0929867013373165","pdf_url":null,"source":{"id":"https://openalex.org/S33159018","display_name":"Current Medicinal Chemistry","issn_l":"0929-8673","issn":["0929-8673","1875-533X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320079","host_organization_name":"Bentham Science Publishers","host_organization_lineage":["https://openalex.org/P4310320079"],"host_organization_lineage_names":["Bentham Science Publishers"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medicinal Chemistry","raw_type":"journal-article"},{"id":"pmid:11281847","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11281847","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current medicinal chemistry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2033041174","https://openalex.org/W2048894494","https://openalex.org/W2166403013","https://openalex.org/W2022830425","https://openalex.org/W2158623108","https://openalex.org/W2002139917","https://openalex.org/W2138672171","https://openalex.org/W2017044647","https://openalex.org/W2047025388","https://openalex.org/W2193877390"],"abstract_inverted_index":{"Agonists":[0],"of":[1,15,18,33,60,82,85,196,208],"the":[2,23,31,34,37,65,77,80,88,92,115,118,123,135,143,156,169,180,185,190,202,205,209],"alpha4beta2":[3],"nicotinic":[4,25,89],"acetylcholine":[5,90],"receptors":[6,91],"have":[7],"been":[8],"synthesised":[9],"as":[10],"potential":[11],"drugs":[12],"for":[13,87],"treatment":[14],"a":[16,98,126,130,138,149,162,173],"variety":[17],"diseases.":[19],"In":[20],"this":[21],"review,":[22],"published":[24],"agonists":[26],"are":[27,39,71,95],"presented":[28],"and,":[29],"on":[30],"basis":[32,81],"molecular":[35],"structure,":[36],"compounds":[38,51],"divided":[40],"into":[41],"three":[42],"compound":[43],"classes,":[44],"nicotinoids":[45],"(structurally":[46,52,62],"close":[47,53,63],"to":[48,54,64],"nicotine),":[49],"bicyclic":[50],"epibatidine":[55],"and":[56,58,74,97,117,137,158,184,192,198,204],"anatoxin-a),":[57],"analogues":[59],"imidacloprid":[61],"insecticide":[66],"imidacloprid).":[67],"The":[68,103],"structure-activity":[69,93],"relationships":[70,94],"discussed":[72,96],"within":[73],"in":[75,114,122,134,142,155,168,179,189],"between":[76,110,129,148,176],"classes.":[78],"On":[79],"computational":[83],"studies":[84],"ligands":[86],"possible":[99],"binding":[100,104,170,182],"mode":[101,105],"suggested.":[102],"encompasses:":[106],"(A)":[107],"an":[108,111,146],"interaction":[109,147,175],"anionic":[112],"site":[113,183],"receptor":[116,136,181],"protonated":[119,186],"nitrogen":[120,187],"atom":[121,188],"ligand,":[124,144,191],"(B)":[125],"hydrogen":[127,131,139],"bond":[128,132,140],"donor":[133],"acceptor":[141],"(C)":[145],"pi-system":[150,160],"(heteroaromatic":[151],"ring,":[152],"carbonyl":[153],"bond)":[154],"ligand":[157],"another":[159],"or":[161],"positively":[163],"charged":[164],"amino":[165],"acid":[166],"residue":[167],"site,":[171],"(D)":[172],"pi-cation":[174],"aromatic":[177],"residues":[178],"(E)":[193],"steric":[194],"interactions":[195],"positive":[197],"negative":[199],"character":[200],"around":[201],"aliphatic":[203],"heteroaromatic":[206],"part":[207],"ligand.":[210]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W82844231","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
